Expression of human H-type alpha1,2-fucosyltransferase encoding for blood group H(O) antigen in Chinese hamster ovary cells. Evidence for preferential fucosylation and truncation of polylactosamine sequences.
The human H(O) blood group is specified by the structure Fucalpha1-2Galbeta1-R, but the factors regulating expression of this determinant on cell surface glycoconjugates are not well understood. To learn more about the regulation of H blood group expression, cDNA encoding the human H-type GDPFuc:beta-D-galactoside alpha1, 2-fucosyltransferase (alpha1,2FT) was stably transfected into Chinese hamster ovary (CHO) cells. The new cell line, designated CHO(alpha1,2)FT, expressed surface neoglycans containing the H antigen. The structures of the fucosylated neoglycans in CHO(alpha1, 2)FT cells and the distribution of these glycans on glycoproteins were characterized. Seventeen percent of the [3H]Gal-labeled glycopeptides from CHO(alpha1,2)FT cells bound to the immobilized H blood group-specific lectin Ulex europaeus agglutinin-I (UEA-I), whereas none from parental CHO cells bound to the lectin. The glycopeptides from CHO(alpha1,2)FT cells binding to UEA-I contained polylactosamine [3Galbeta1-4GlcNAcbeta1-]n with the terminal sequence Fucalpha1-2Galbeta1- 4GlcNAc-R. Fucosylation of the polylactosamine sequences on complex-type N-glycans in CHO(alpha1, 2)FT cells caused a decrease in both sialylation and length of polylactosamine. Unexpectedly, only small amounts of terminal fucosylation was found in diantennary complex-type N-glycans. The O-glycans and glycolipids were not fucosylated by the H-type alpha1, 2FT. Two major high molecular weight glycoproteins, one of which was shown to be the lysosome-associated membrane glycoprotein LAMP-1, preferentially contained the H-type structure and were bound by immobilized UEA-I. These results demonstrate that in CHO cells the expressed H-type alpha1,2FT does not indiscriminately fucosylate terminal galactosyl residues in complex-type N-glycans, but it favors glycans containing polylactosamine and dramatically alters their length and sialylation.
Prieto
P A
PA
Department of Biochemistry and Molecular Biology, University of Georgia, Athens, Georgia 30602, USA.
Larsen
R D
RD
Cho
M
M
Rivera
H N
HN
Shilatifard
A
A
Lowe
J B
JB
Cummings
R D
RD
Smith
D F
DF
D000017:ABO Blood-Group System; D000606:Amino Sugars / Q000737:chemistry*; D000818:Animals; D015703:Antigens, CD / Q000378:metabolism; D001345:Autoradiography; D016466:CHO Cells; D002851:Chromatography, High Pressure Liquid; D002854:Chromatography, Paper; D006224:Cricetinae; D003412:Cricetulus; D005434:Flow Cytometry; D005643:Fucose / Q000378:metabolism; D005647:Fucosyltransferases / Q000378:metabolism*; D006801:Humans; D051907:Lysosomal Membrane Proteins; D008247:Lysosomes / Q000378:metabolism; D008562:Membrane Glycoproteins / Q000378:metabolism; D019081:O Antigens / Q000737:chemistry*; D011134:Polysaccharides / Q000737:chemistry* / Q000378:metabolism; D000097631:Galactoside 2-alpha-L-fucosyltransferase
D000017:ABO Blood-Group System; D000606:Amino Sugars; D015703:Antigens, CD; D005643:Fucose; D005647:Fucosyltransferases; D051907:Lysosomal Membrane Proteins; D008562:Membrane Glycoproteins; D019081:O Antigens; D011134:Polysaccharides; D000097631:Galactoside 2-alpha-L-fucosyltransferase; C066929:polylactosamine